1. Home
  2. NVAX vs WYFI Comparison

NVAX vs WYFI Comparison

Compare NVAX & WYFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • WYFI
  • Stock Information
  • Founded
  • NVAX 1987
  • WYFI 2023
  • Country
  • NVAX United States
  • WYFI United States
  • Employees
  • NVAX N/A
  • WYFI N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • WYFI Finance: Consumer Services
  • Sector
  • NVAX Health Care
  • WYFI Finance
  • Exchange
  • NVAX Nasdaq
  • WYFI Nasdaq
  • Market Cap
  • NVAX 1.3B
  • WYFI 1.2B
  • IPO Year
  • NVAX 1995
  • WYFI 2025
  • Fundamental
  • Price
  • NVAX $8.31
  • WYFI $26.80
  • Analyst Decision
  • NVAX Hold
  • WYFI Strong Buy
  • Analyst Count
  • NVAX 5
  • WYFI 6
  • Target Price
  • NVAX $9.80
  • WYFI $31.17
  • AVG Volume (30 Days)
  • NVAX 4.6M
  • WYFI 1.4M
  • Earning Date
  • NVAX 11-11-2025
  • WYFI 12-09-2025
  • Dividend Yield
  • NVAX N/A
  • WYFI N/A
  • EPS Growth
  • NVAX N/A
  • WYFI N/A
  • EPS
  • NVAX 2.54
  • WYFI N/A
  • Revenue
  • NVAX $1,078,718,000.00
  • WYFI $62,303,715.00
  • Revenue This Year
  • NVAX $60.81
  • WYFI $83.44
  • Revenue Next Year
  • NVAX N/A
  • WYFI $130.45
  • P/E Ratio
  • NVAX $3.38
  • WYFI N/A
  • Revenue Growth
  • NVAX 9.22
  • WYFI N/A
  • 52 Week Low
  • NVAX $5.01
  • WYFI $14.01
  • 52 Week High
  • NVAX $11.55
  • WYFI $40.75
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 46.18
  • WYFI N/A
  • Support Level
  • NVAX $8.02
  • WYFI N/A
  • Resistance Level
  • NVAX $8.83
  • WYFI N/A
  • Average True Range (ATR)
  • NVAX 0.47
  • WYFI 0.00
  • MACD
  • NVAX -0.09
  • WYFI 0.00
  • Stochastic Oscillator
  • NVAX 17.05
  • WYFI 0.00

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About WYFI WhiteFiber Inc. Ordinary Shares

Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.

Share on Social Networks: